Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
22 Janeiro 2024 - 6:05PM
Business Wire
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin
delivery and diabetes technology company, plans to release its
fourth quarter and full year 2023 results after the financial
markets close on Wednesday, February 21, 2024. The Company will
hold a conference call and simultaneous webcast on the same day at
4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its fourth
quarter and full year 2023 financial and operating results.
A live webcast of the call will be available on Tandem Diabetes
Care’s Investor Center website located at
http://investor.tandemdiabetes.com in the “Events &
Presentations” section. To access the call by phone, please use
this link
(https://register.vevent.com/register/BIa95db72e0b404258a57afd8b48cc6915)
and you will be provided with dial-in details, including a personal
pin.
An archive of the webcast will be available for 30 days
following the event on Tandem Diabetes Care’s Investor Center
website located at http://investor.tandemdiabetes.com in the
“Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc., a global insulin delivery and
diabetes technology company based in San Diego, California, creates
new possibilities for people living with diabetes, their loved
ones, and healthcare providers through a positively different
experience. The Company’s human-centered approach to design,
development, and support delivers innovative products and services
for people who use insulin. Tandem manufactures and sells the
t:slim X2 insulin pump with Control-IQ technology. For more
information, visit tandemdiabetes.com.
Tandem Diabetes Care, t:slim X2, and Control-IQ are either
registered trademarks or trademarks of Tandem Diabetes Care, Inc.
in the US and/or other countries.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use
#tslimX2 and #TandemDiabetes. Follow Tandem Diabetes Care on
Facebook at www.facebook.com/TandemDiabetes. Follow Tandem Diabetes
Care on LinkedIn at
https://www.linkedin.com/company/tandemdiabetes.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240122318175/en/
Media Contact: 858-366-6900 media@tandemdiabetes.com
Investor Contact: 858-366-6900 IR@tandemdiabetes.com
Tandem Diabetes Care (NASDAQ:TNDM)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Tandem Diabetes Care (NASDAQ:TNDM)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024